{"id":1589,"date":"2023-03-11T11:29:09","date_gmt":"2023-03-11T11:29:09","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=1589"},"modified":"2023-03-11T11:29:10","modified_gmt":"2023-03-11T11:29:10","slug":"rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/","title":{"rendered":"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding."},"content":{"rendered":"\n
\"Logo<\/figure>\n\n\n\n

Rapport Therapeutics<\/a> is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is founded by Abraham (Abe) Ceesay<\/a>, and its investors include Johnson & Johnson<\/a>, ARCH Venture Partners<\/a>, and Third Rock Ventures<\/a>. Rapport’s mission is to create impactful neuro medicines with fewer side effects that allow patients and their families to live healthier and more fulfilling lives. They believe that precision neuro medicines will improve lives by overcoming the limitations of today’s treatments for many neurological conditions. Their approach is to use their deep understanding of the intricate relationships between receptors, their associated proteins, and their distributions in specific cell types and brain regions to precisely direct medicines to the neural circuits underlying disease pathophysiology.<\/p>\n\n\n\n

\"Team<\/figure>\n\n\n\n

Rapport Therapeutics’ strengths lie in their founding scientists’ expertise in the biologic and therapeutic applications of receptor-associated proteins (RAPs). The company’s co-founder and CSO, David Bredt, pioneered RAP discovery more than two decades ago while working at Janssen Neuroscience. Alongside many other scientific leaders, he advanced the idea of harnessing RAPs to target specific neuron circuits. Seeing an opportunity to house this technology in a biotech company, Janssen and Third Rock Ventures partnered to create Rapport in late 2022. Their first program, currently in Phase I clinical development, is designed to treat drug-resistant seizure disorders.<\/p>\n","protected":false},"excerpt":{"rendered":"

Rapport Therapeutics is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is founded by Abraham (Abe) Ceesay, and its investors include Johnson & Johnson, ARCH Venture Partners, and Third Rock Ventures. Rapport’s mission is to create impactful neuro medicines with fewer side effects that allow […]<\/p>\n","protected":false},"author":6,"featured_media":1592,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"\nRapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding. - Founder Lodge Latest News<\/title>\n<meta name=\"description\" content=\"Rapport Therapeutics is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding. - Founder Lodge Latest News\" \/>\n<meta property=\"og:description\" content=\"Rapport Therapeutics is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-11T11:29:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-11T11:29:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/landing-page-9.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1895\" \/>\n\t<meta property=\"og:image:height\" content=\"860\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fasihsheikh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fasihsheikh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/\"},\"author\":{\"name\":\"fasihsheikh\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8\"},\"headline\":\"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding.\",\"datePublished\":\"2023-03-11T11:29:09+00:00\",\"dateModified\":\"2023-03-11T11:29:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/\"},\"wordCount\":233,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/\",\"name\":\"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding. - Founder Lodge Latest News\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-03-11T11:29:09+00:00\",\"dateModified\":\"2023-03-11T11:29:10+00:00\",\"description\":\"Rapport Therapeutics is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who's raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8\",\"name\":\"fasihsheikh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g\",\"caption\":\"fasihsheikh\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/fasihsheikh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding. - Founder Lodge Latest News","description":"Rapport Therapeutics is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/","og_locale":"en_US","og_type":"article","og_title":"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding. - Founder Lodge Latest News","og_description":"Rapport Therapeutics is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is","og_url":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-03-11T11:29:09+00:00","article_modified_time":"2023-03-11T11:29:10+00:00","og_image":[{"width":1895,"height":860,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/landing-page-9.jpg","type":"image\/jpeg"}],"author":"fasihsheikh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fasihsheikh","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/"},"author":{"name":"fasihsheikh","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8"},"headline":"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding.","datePublished":"2023-03-11T11:29:09+00:00","dateModified":"2023-03-11T11:29:10+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/"},"wordCount":233,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/","url":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/","name":"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding. - Founder Lodge Latest News","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-03-11T11:29:09+00:00","dateModified":"2023-03-11T11:29:10+00:00","description":"Rapport Therapeutics is a biotechnology research startup based in Boston, Massachusetts that recently raised $120M in Series A funding. The company is","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/rapport-therapeutics-is-a-biotechnology-research-startup-that-recently-raised-120m-in-series-a-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Rapport Therapeutics is a biotechnology research startup that recently raised $120M in Series A funding."}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who's raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8","name":"fasihsheikh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g","caption":"fasihsheikh"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/fasihsheikh\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1589"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=1589"}],"version-history":[{"count":2,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1589\/revisions"}],"predecessor-version":[{"id":1594,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1589\/revisions\/1594"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/1592"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=1589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=1589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=1589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}